Kevin Punie

35PUBLICATIONS
317CO-AUTHORS
Molecular targetsRadiation therapyCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersLiquid biopsies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (35)

|Sep 21, 2026
Safety and Efficacy of Ceralasertib plus Olaparib for Advanced/Metastatic Triple-Negative Breast Cancer in Three Molecular Strata: The Phase II VIOLETTE Study.

|Apr 28, 2026
Preoperative Radiation Therapy and Immediate Breast Reconstruction, a phase 3 randomized controlled trial in the Belgian population (PRADAIIBE): a study protocol.

|Jun 25, 2025
Q-TWiST Analysis to Assess Benefit-Risk of Sacituzumab Govitecan in Previously Treated Patients With Metastatic Triple-Negative Breast Cancer.

Aditya Bardia, Hope S Rugo, Mina S Sedrak

|Mar 31, 2025
Unmet need for previously untreated metastatic triple-negative breast cancer: a real-world study of patients diagnosed from 2011 to 2022 in the United States.

Kevin Punie, Allison W Kurian, Ioanna Ntalla

|Oct 23, 2024
Trastuzumab Duocarmazine in Pretreated Human Epidermal Growth Factor Receptor 2-Positive Advanced or Metastatic Breast Cancer: An Open-Label, Randomized, Phase III Trial (TULIP).

Nicholas Turner, Cristina Saura, Philippe Aftimos

|Apr 24, 2024
Rapid autopsies to enhance metastatic research: the UPTIDER post-mortem tissue donation program.

Tatjana Geukens, Maxim De Schepper, Wouter Van Den Bogaert

Pageof 6

Frequent Collaborators

10 joint publications

Hans Wildiers

7 joint publications

Martine Piccart-Gebhart

7 joint publications

Giuseppe Floris

7 joint publications

Ann Smeets